Cantourage Group (HIGH) Q2 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 TU earnings summary
23 Jun, 2026Executive summary
Achieved record revenue of EUR 27.9 million in Q2 2025, marking the strongest quarter in company history.
Year-to-date revenue reached EUR 54.0 million, already surpassing the full-year 2024 revenue of EUR 51.4 million.
Revenue growth exceeded 130% compared to Q2 2024 (EUR 12.0 million).
Financial highlights
Q2 2025 revenue: EUR 27.9 million, up from EUR 12.0 million in Q2 2024.
Year-to-date 2025 revenue: EUR 54.0 million, exceeding 2024's total annual revenue.
All figures are preliminary, unaudited, and unconsolidated.
Outlook and guidance
Strong demand continues in Germany and internationally, supported by expanded processing capacities and new suppliers.
Positioned for continued successful market operations due to industry partnerships.
Latest events from Cantourage Group
- Net profit surged to €210,989.14 in H1 2024, driven by higher revenue and one-time income.HIGH
H1 202423 Jun 2026 - Revenue and net income grew strongly, with all earnings retained and a clean audit opinion.HIGH
H2 202423 Jun 2026 - Q1 2025 revenue soared to EUR 25.6 million, quadrupling year-over-year on robust European demand.HIGH
Q1 2025 TU23 Jun 2026 - Profitable, asset-light cannabis platform drives growth with innovation and telemedicine.HIGH
Investor presentation23 Jun 2026 - Revenue and profit fell, but equity and liquidity remain robust amid higher compliance costs.HIGH
H1 202523 Jun 2026 - Revenue up 148% year-over-year to EUR 75 million, with strong growth and European expansion plans.HIGH
Q3 2025 TU23 Jun 2026 - Revenue up 78% to €3.9M, net income €126K, audit unqualified, all sales intra-group.HIGH
H2 202523 Jun 2026 - Q1 2026 saw higher profitability, strong UK growth, and a robust financial position.HIGH
Q1 2026 TU23 Jun 2026